C40-C41 Malignant neoplasms of bones and articular cartilage - analogs
| Description «C40-C41 Malignant neoplasms of bones and articular cartilage» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C40 Malignant neoplasm of bone and articular cartilage of limbs
- 30% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 30% Compare C41.0 Malignant neoplasm, bones of skull and face
- 30% Compare C40.9 Malignant neoplasm, bone and articular cartilage of limb, unspecified
- 30% Compare C40.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage of limbs
- 30% Compare C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- 23% Compare C40.2 Malignant neoplasm, long bones of lower limb
- 23% Compare C40.3 Malignant neoplasm, short bones of lower limb
- 23% Compare C40.0 Malignant neoplasm, scapula and long bones of upper limb
- 23% Compare C40.1 Malignant neoplasm, short bones of upper limb
- 23% Compare C41.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage
- 10% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 10% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C54.1 Malignant neoplasm, endometrium
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C67.9 Malignant neoplasm, bladder, unspecified
- 10% Compare C92.5 Acute myelomonocytic leukaemia
- 10% Compare D29.0 Benign neoplasm, penis
- 10% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 10% Compare C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C22.9 Malignant neoplasm, liver, unspecified
- 10% Compare C51.9 Malignant neoplasm, vulva, unspecified
- 10% Compare C67 Malignant neoplasm of bladder
- 10% Compare C30 Malignant neoplasm of nasal cavity and middle ear
- 10% Compare C95.0 Acute leukaemia of unspecified cell type
- 10% Compare D16.4 Benign neoplasm, bones of skull and face
- 10% Compare C94 Other leukaemias of specified cell type
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare C32 Malignant neoplasm of larynx
- 10% Compare C91 Lymphoid leukaemia
- 10% Compare C38.3 Malignant neoplasm, mediastinum, part unspecified
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C22.7 Malignant neoplasm, other specified carcinomas of liver
- 10% Compare C94.2 Acute megakaryoblastic leukaemia
- 10% Compare C38.1 Malignant neoplasm, anterior mediastinum
- 10% Compare C30.0 Malignant neoplasm, nasal cavity
- 10% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
- 10% Compare C71.0 Malignant neoplasm, cerebrum, except lobes and ventricles
- 10% Compare C15.4 Malignant neoplasm, middle third of oesophagus
- 10% Compare C15 Malignant neoplasm of oesophagus
- 10% Compare C13.8 Malignant neoplasm, overlapping lesion of hypopharynx
- 10% Compare C70 Malignant neoplasm of meninges
- 10% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare D01.4 Carcinoma in situ, other and unspecified parts of intestine
- 10% Compare C74.9 Malignant neoplasm, adrenal gland, unspecified
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.